Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Renovaro Inc (RENB)

Renovaro Inc (RENB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 100,982
  • Shares Outstanding, K 147,505
  • Annual Sales, $ 0 K
  • Annual Income, $ -39,680 K
  • 60-Month Beta 0.60
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.70
Trade RENB with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.70
  • Most Recent Earnings $-0.08 on 05/15/24
  • Next Earnings Date 10/07/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 172.47% ( -25.79%)
  • Historical Volatility 201.13%
  • IV Percentile 48%
  • IV Rank 20.51%
  • IV High 634.16% on 10/20/23
  • IV Low 53.33% on 08/16/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 20
  • Volume Avg (30-Day) 123
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 1,606
  • Open Int (30-Day) 1,570

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.4200 +63.00%
on 08/01/24
1.3694 -50.01%
on 07/29/24
-0.6454 (-48.53%)
since 07/23/24
3-Month
0.4200 +63.00%
on 08/01/24
2.3400 -70.74%
on 06/10/24
-0.6354 (-48.14%)
since 05/23/24
52-Week
0.4200 +63.00%
on 08/01/24
5.2500 -86.96%
on 01/25/24
-1.3154 (-65.77%)
since 08/23/23

Most Recent Stories

More News
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:RENB),(NASDAQ:CYTO),(NYSE:PFE),(NYSE:ABBV) EQNX::TICKER_END

ONCY : 0.9900 (+4.21%)
ONC.TO : 1.34 (+3.08%)
RENB : 0.6846 (+4.01%)
CYTO : 0.9553 (-2.96%)
PFE : 28.90 (+0.42%)
ABBV : 197.55 (+0.60%)
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to $7.4 Billion By 2032

ONCY : 0.9900 (+4.21%)
ONC.TO : 1.34 (+3.08%)
RENB : 0.6846 (+4.01%)
CYTO : 0.9553 (-2.96%)
PFE : 28.90 (+0.42%)
ABBV : 197.55 (+0.60%)
Renovaro BioSciences (NASDAQ: RENB) Announces Results of Special Meeting

Renovaro BioSciences (NASDAQ: RENB), a biotechnology corporation focusing on cell, gene and immunotherapy, has announced the results of its special meeting of shareholders (“special meeting”) held...

RENB : 0.6846 (+4.01%)
Renovaro BioSciences (NASDAQ: RENB) Releases CEO Shareholder Message

Renovaro BioSciences (NASDAQ: RENB) (formerly NASDAQ: ENOB), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, has released...

NVDA : 129.37 (+4.55%)
RENB : 0.6846 (+4.01%)
ENOB : 0.7000 (unch)
Renovaro BioSciences (NASDAQ: RENB) CEO Featured in Recent Proactive Interview

Renovaro BioSciences (NASDAQ: RENB) (formerly NASDAQ: ENOB), an advanced, preclinical biotechnology firm in cell, gene and immunotherapy focused on solid tumors with short life expectancy, was featured...

RENB : 0.6846 (+4.01%)
ENOB : 0.7000 (unch)
Renovaro BioSciences (NASDAQ: RENB) Poised to Spearhead Advancements in Battle Against Diseases

Renovaro BioSciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene and immunotherapy, recently announced a definitive agreement to combine with the advanced AI company GEDiCube...

INTC : 20.54 (+2.19%)
RENB : 0.6846 (+4.01%)
Renovaro BioSciences (NASDAQ: RENB) Eyes Opportunity in Precision Medicine Market

Renovaro BioSciences (NASDAQ: RENB), an advanced, preclinical biotechnology company, and GEDi Cube Intl Ltd., an AI medical technology company, previously announced a definitive agreement to combine. The...

RENB : 0.6846 (+4.01%)
Unlocking AI investment opportunities in healthcare

AI is revolutionizing healthcare by improving diagnosis and accelerating drug discovery. An often-overlooked sector with a wealth of AI opportunities.

INTC : 20.54 (+2.19%)
NVDA : 129.37 (+4.55%)
RXRX : 7.81 (+6.26%)
RLAY : 7.20 (+3.75%)
EXAI : 6.00 (+5.63%)
RENB : 0.6846 (+4.01%)
BTAI : 0.6790 (+4.13%)
Renovaro Biosciences (NASDAQ: RENB) CEO Provides Update on Combination with GEDiCube

In September, Renovaro Biosciences (NASDAQ: RENB), an advanced, preclinical biotechnology company focused on cell, gene, and immunotherapy, and GEDiCube Intl Ltd., an AI medical technology company, announced...

RENB : 0.6846 (+4.01%)
Renovaro BioSciences (NASDAQ: RENB), GEDi Cube Combine to Transform Medicine Through AI, Biotherapeutics

Renovaro BioSciences (NASDAQ: RENB), a preclinical biotechnology company involved in the development of enhanced gene, cell and immunotherapy platforms that modulate immune responses against cancers and...

RENB : 0.6846 (+4.01%)

Business Summary

Renovaro Inc. includes RenovaroCube and Renovaro Biosciences. Renovaro Biosciences is an advanced cell-gene-immunotherapy company. Its lead candidate product is a therapeutic vaccine targeting cancers which are difficult to treat including pancreatic and potentially HNC, triple-negative breast cancer,...

See More

Key Turning Points

3rd Resistance Point 0.7579
2nd Resistance Point 0.7308
1st Resistance Point 0.7077
Last Price 0.6846
1st Support Level 0.6575
2nd Support Level 0.6304
3rd Support Level 0.6073

See More

52-Week High 5.2500
Fibonacci 61.8% 3.4049
Fibonacci 50% 2.8350
Fibonacci 38.2% 2.2651
Last Price 0.6846
52-Week Low 0.4200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar